company background image

EnBio Holdings TSE:6092 Stock Report

Last Price


Market Cap







25 Sep, 2022


Company Financials
6092 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance5/6
Financial Health4/6

6092 Stock Overview

EnBio Holdings, Inc engages in soil and groundwater contamination, and renewable energy businesses in Japan.

EnBio Holdings Competitors

Price History & Performance

Summary of all time highs, changes and price drops for EnBio Holdings
Historical stock prices
Current Share PriceJP¥659.00
52 Week HighJP¥1,090.00
52 Week LowJP¥515.00
1 Month Change4.11%
3 Month Change20.70%
1 Year Change8.57%
3 Year Change-30.92%
5 Year Change-55.95%
Change since IPO-59.09%

Recent News & Updates

Shareholder Returns

6092JP Commercial ServicesJP Market

Return vs Industry: 6092 exceeded the JP Commercial Services industry which returned -6.9% over the past year.

Return vs Market: 6092 exceeded the JP Market which returned -9.1% over the past year.

Price Volatility

Is 6092's price volatile compared to industry and market?
6092 volatility
6092 Average Weekly Movement6.9%
Commercial Services Industry Average Movement3.3%
Market Average Movement3.5%
10% most volatile stocks in JP Market7.4%
10% least volatile stocks in JP Market1.8%

Stable Share Price: 6092 is more volatile than 75% of JP stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: 6092's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.

About the Company

199980Minoru Nishimura

EnBio Holdings, Inc engages in soil and groundwater contamination, and renewable energy businesses in Japan. It engages in the soil contamination countermeasures businesses; brownfield utilization businesses; renewable energy power generation business with capacity of 36,239 kw; water resource development projects; regional biomass utilization development projects; and ethical consumption promotion businesses. The company was incorporated in 1999 and is headquartered in Tokyo, Japan.

EnBio Holdings Fundamentals Summary

How do EnBio Holdings's earnings and revenue compare to its market cap?
6092 fundamental statistics
Market CapJP¥4.38b
Earnings (TTM)JP¥894.00m
Revenue (TTM)JP¥9.73b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
6092 income statement (TTM)
Cost of RevenueJP¥6.93b
Gross ProfitJP¥2.80b
Other ExpensesJP¥1.91b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Nov 14, 2022

Earnings per share (EPS)134.54
Gross Margin28.79%
Net Profit Margin9.18%
Debt/Equity Ratio133.9%

How did 6092 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
We’ve recently updated our valuation analysis.


Is 6092 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6092?

Other financial metrics that can be useful for relative valuation.

6092 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1x
Enterprise Value/EBITDA5.3x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 6092's PE Ratio compare to its peers?

6092 PE Ratio vs Peers
The above table shows the PE ratio for 6092 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average24.1x
6044 Sanki Service
1438 Gifu landscape architect
5699 IBOKINLtd
3267 Phil CompanyInc
6092 EnBio Holdings

Price-To-Earnings vs Peers: 6092 is good value based on its Price-To-Earnings Ratio (4.9x) compared to the peer average (24.1x).

Price to Earnings Ratio vs Industry

How does 6092's PE Ratio compare vs other companies in the JP Commercial Services Industry?

Price-To-Earnings vs Industry: 6092 is good value based on its Price-To-Earnings Ratio (4.9x) compared to the JP Commercial Services industry average (13.5x)

Price to Earnings Ratio vs Fair Ratio

What is 6092's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6092 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio4.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 6092's Price-To-Earnings Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of 6092 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 6092 (¥659) is trading below our estimate of fair value (¥2402.01)

Significantly Below Fair Value: 6092 is trading below fair value by more than 20%.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Future Growth

How is EnBio Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score


Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted Commercial Services industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as EnBio Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Discover growth companies

  • Examine whether EnBio Holdings is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.

Past Performance

How has EnBio Holdings performed over the past 5 years?

Past Performance Score


Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 6092 has high quality earnings.

Growing Profit Margin: 6092's current net profit margins (9.2%) are higher than last year (4.3%).

Past Earnings Growth Analysis

Earnings Trend: 6092's earnings have grown significantly by 21.1% per year over the past 5 years.

Accelerating Growth: 6092's earnings growth over the past year (226.3%) exceeds its 5-year average (21.1% per year).

Earnings vs Industry: 6092 earnings growth over the past year (226.3%) exceeded the Commercial Services industry 19.1%.

Return on Equity

High ROE: 6092's Return on Equity (14.8%) is considered low.

Discover strong past performing companies

Financial Health

How is EnBio Holdings's financial position?

Financial Health Score


Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 6092's short term assets (¥6.7B) exceed its short term liabilities (¥3.5B).

Long Term Liabilities: 6092's short term assets (¥6.7B) do not cover its long term liabilities (¥6.9B).

Debt to Equity History and Analysis

Debt Level: 6092's net debt to equity ratio (87.3%) is considered high.

Reducing Debt: 6092's debt to equity ratio has reduced from 314.9% to 133.9% over the past 5 years.

Debt Coverage: 6092's debt is well covered by operating cash flow (28.2%).

Interest Coverage: 6092's interest payments on its debt are well covered by EBIT (13.9x coverage).

Balance Sheet

Discover healthy companies


What is EnBio Holdings's current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 2/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 6092's dividend (1.21%) isn’t notable compared to the bottom 25% of dividend payers in the JP market (1.65%).

High Dividend: 6092's dividend (1.21%) is low compared to the top 25% of dividend payers in the JP market (3.67%).

Stability and Growth of Payments

Stable Dividend: Too early to tell whether 6092's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if 6092's dividend payments are increasing as they only just started paying a dividend.

Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (5.9%), 6092's dividend payments are thoroughly covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (4.3%), 6092's dividend payments are thoroughly covered by cash flows.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Average board tenure


Minoru Nishimura (64 yo)



Mr. Minoru Nishimura, Ph.D. serves as Co-President and Co-Chief Executive Officer of EnBioTec Laboratories Co., Ltd. Mr. Nishimura has been the President of Enbio Holdings, Inc. since January 2008 and serv...

Board Members

Experienced Board: 6092's board of directors are considered experienced (9.8 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 23 shareholders own 52.01% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
CRE, Inc.
1,280,000¥843.5m0%no data
Minoru Nishimura
509,100¥335.5m0%no data
Yoshikazu Nakamura
502,000¥330.8m0%no data
Koichiro Hirata
200,000¥131.8m0%no data
SBI Holdings Inc., Asset Management Arm
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
99,700¥65.7m0%no data
Morgan Stanley, Investment Banking and Brokerage Investments
95,500¥62.9m0%no data
Tetsushi Nakama
80,500¥53.0m0%no data
Kunio Orita
80,000¥52.7m0%no data
Takahisa Nagai
74,000¥48.8m0%no data
Nomura Holdings Inc, Securities & Investment Arm
67,585¥44.5m0%no data
Sakura General Surface Limited
60,000¥39.5m0%no data
Kento Arakawa
58,000¥38.2m0%no data
Rakuten Investment Management, Inc.
Toyoko Osawa
55,000¥36.2m0%no data
Hitoshi Yamauchi
51,500¥33.9m0%no data
Shusaku Kusaba
21,000¥13.8m23.53%no data
Toshihito Yamamoto
15,500¥10.2m106.67%no data
Yukinobu Yokomizo
14,100¥9.3m39.6%no data
Ichiro Namekawa
11,000¥7.2m22.22%no data
Takahiro Hoshino
10,000¥6.6m0%no data
Yuki Odake
1,000¥659.0k0%no data
Tadahide Kameyama
100¥65.9k0%no data

Company Information

EnBio Holdings, Inc's employee growth, exchange listings and data sources

Key Information

  • Name: EnBio Holdings, Inc
  • Ticker: 6092
  • Exchange: TSE
  • Founded: 1999
  • Industry: Environmental and Facilities Services
  • Sector: Commercial Services
  • Implied Market Cap: JP¥4.379b
  • Shares outstanding: 6.64m
  • Website:

Number of Employees


  • EnBio Holdings, Inc
  • Kanda Park Plaza
  • 8th floor
  • Tokyo
  • 101-0044
  • Japan


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
6092TSE (The Tokyo Stock Exchange)YesCommon SharesJPJPYMar 2014

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/25 00:00
End of Day Share Price2022/09/22 00:00
Annual Earnings2022/03/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.